Peripheral blood progenitor cells for marrow reconstitution: Mobilization and collection strategies

Transfusion

Volumn 36, Issue 7, 1996, Pages 611-624

  Gillespie, T W ^a   Hillyer, C D ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; STEM CELL FACTOR;

APHERESIS; BONE MARROW TRANSPLANTATION; COLONY FORMATION; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKAPHERESIS; PATIENT CARE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION;

EID: 0030017031     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36796323060.x     Document Type: Review

References (123)

1. Bensinger WI, WeaverCH. Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-8.
2. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-72.
3. Henon P. New developments in peripheral blood stem cell transplants. Leukemia 1992;6 Suppl 4:106-9.
4. Hillyer CD, Wells SJ. Alternative sources of hematopoietic stem cells for bone marrow transplantation and rescue. J Hematother 1993;2:491-9.
5. Gianni AM, Siena S, Bregni M, et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989;2:580-5.
6. Lopez M, Mortel O, Pouillart P, et al. Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells. Bone Marrow Transplant 1991;7:173-81.
7. Hillyer CD. Large volume leukapheresis to maximize peripheral blood stem cell collection. J Hematother 1993;2:529-32.
8. Malachowski ME, Comenzo RL, Hillyer CD, et al. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992;32:732-5.
9. Comenzo RL, Vosburgh E, Weintraub LR, et al. Collection of mobilized blood progenitor cells for hematopoietic rescue by large-volume leukapheresis. Transfusion 1995;35:493-7.
10. Kessinger A. Autologous transplantation with peripheral blood stem cells. A review of clinical results. J Clin Apheresis 1990;5:97-9.
11. Baum CM, Weissman IL, Tsukamoto AS, et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992;89:2804-8.
12. Kerst JM, Slaper-Cortenbach IC, von dem Borne AE, et al. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis. Exp Hematol 1992;20:1188-93.
13. Wright Goodman J, Hodgson GS. Evidence of stem cells in the peripheral blood of mice. Blood 1962;19:702-14.
14. Epstein RB, Graham TC, Buckner CD, et al. Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs. Blood 1966;28:692-707.
15. Hillyer CD, Swenson RB, Hart KK, et al. Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model. Exp Hematol 1993;21:1455-9.
16. Storb R, Graham TC, Epstein RB, et al. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977;50:537-42.
17. McCredie KB, Hersh EM, Freireich EJ. Cells capable of colony formation in the peripheral blood of man. Science 1971;171:293-4.
18. Del Monte C, Basso P, Consoli P, et al. Collection of peripheral blood stem cells by apheresis with continuous flow blood cell separator Dideco Vivacell. Haematologica 1990;75 Suppl 1:18-21.
19. Hillyer CD, Tiegerman KO, Berkman EM. Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991;31:327-32.
20. Indovina A, Scime R, Vasta S, et al. Collection of PBSC with Fenwal CS-3000 for autografting. Haematologica 1990;75 Suppl 1:26-8.
21. Pierelli L, Menichella G, Paoloni A, et al. Collection of peripheral blood stem cells using an automated discontinuous flow blood cell separator. Haematologica 1990;75 Suppl 1:29-32.
22. Kessinger A, Bierman PJ, Vose JM, Armitage JO. High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease. Blood 1991;77:2322-5.
23. Juttner CA, To LB, Haylock DN, et al. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br J Haematol 1985;61:739-45.
24. Korbling M, Dorken B, Ho AD, et al. Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 1986;67:529-32.
25. Williams SF, Mick R, Desser R, et al. High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. J Clin Oncol 1989;7:1824-30.
26. Kessinger A, Armitage JO, Smith DM, et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 1989;74:1260-5.
27. To LB, Haylock DN, Kimber RJ, Juttner CA. High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol 1984;58:399-410.
28. Pettengell R, Demuynck H, Testa NG, Dexter TM. The engraftment capacity of peripheral blood progenitor cells (PBPC) mobilised with chemotherapy ± G-CSF. Int J Cell Cloning 1992;10(Suppl):59-61.
29. Siena S, Bregni M, Brando B, et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989;74:1905-14.
30. To LB, Shepperd KM, Haylock DN, et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990;18:442-7.
31. Abrams RA, Glaubiger D, Appelbaum FR, Deisseroth AB. Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report. Blood 1980;56:516-20.
32. Haines ME, Goldman JM, Worsley AM, et al. Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients. Br J Haematol 1984;58:711-21.
33. Tilly H, Bastit D, Lucet JC, et al. Haemopoietic reconstitution after autologous peripheral blood stem cell transplantation in acute leukaemia (letter). Lancet 1986;2:154-5.
34. Watanabe T, Takaue Y, Kawano Y, et al. Peripheral blood stem cell autotransplantation in treatment of childhood cancer. Bone Marrow Transplant 1989;4:261-5.
35. Reiffers J, Bernard P, David B, et al. Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol 1986;14:312-5.
36. Zander AR, Cockerill KJ. Autologous transplantation with circulating hemopoietic stem cells. J Clin Apheresis 1987;3:191-201.
37. Williams SF, Bitran JD, Richards JM, et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990;5:129-33.
38. 2 cyclophosphamide for peripheral blood stem cell mobilization. Int J Cell Cloning 1992;10(Suppl):33-4.
39. Molineux G, Pojda Z, Hampson IN, et al. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990;76:2153-8.
40. Tarella C, Ferrero D, Bregni M, et al. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991;27:22-7.
41. Gabrilove JL, Jakubowski A, Fain K, et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988;82:1454-61.
42. Gianni AM, Tarella C, Siena S, et al. Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells. Bone Marrow Transplant 1990;6:143-5.
43. Sheridan WP, Begley CG, To LB, et al. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 1994;14:105-11.
44. Bishop MR, Anderson JR, Jackson JD, et al. High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1994;83:610-6.
45. Haas R, Ho AD, Bredthauer U, et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990;18:94-8.
46. Bolwell BJ, Goormastic M, Yanssens T, et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994;14:913-8.
47. Matsunaga T, Sakamaki S, Kohgo Y, et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993;11:103-8.
48. Andrews RG, Briddell RA, Knitter GH, et al. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 1995;85:15-20.
49. De Revel T, Appelbaum FR, Storb R, et al. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 1994;83:3795-9.
50. Andrews RG, Bensinger WI, Knitter GH, et al. The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 1992;80:2715-20.
51. McNiece IK, Briddell RA, Yan XQ, et al. The role of stem cell factor in mobilization of peripheral blood progenitor cells. Leuk Lymphoma 1994;15:405-9.
52. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A 1993;90:9374-8.
53. Haynes A, Hunter A, McQuaker G, et al. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995;16:359-63.
54. Anderson KC. Autologous peripheral blood progenitor cell transplantation. J Clin Apheresis 1995;10:131-8.
55. Olivieri A, Offidani M, Ciniero L, et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994;14:273-8.
56. Bender JG, To LB, Williams S, et al. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-41.
57. Boogaerts MA, Demuynck H. The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor. Eur J Cancer 1994;30A Suppl 3:534-9.
58. Hillyer CD, Lackey DA 3d, Hart KK, et al. CD34+ progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation. Transfusion 1993;33:316-21.
59. Bolin RB, Stewart DA, Cheney BA, et al. Granulocyte progenitor cell (CFUC) harvest by continuous apheresis in dogs. Effects of blood volume and lithium on yields. Exp Hematol 1983;11:226-30.
60. Comenzo RL, Malachowski ME, Miller KB, et al. Engraftment with peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma. Transfusion 1992;32:729-31.
61. Passos-Coelho JL, Braine HG, Davis JM, et al. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995;13:705-14.
62. Comenzo RL, Malachowski ME, Miller KB, et al. Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease. Transfusion 1995;35:42-5.
63. Pettengell R, Morgenstern GR, Woll PJ, et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993;82:3770-7.
64. Passos-Coelho JL, Braine HG, Wright SK, et al. Large-volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells. J Hematother 1995;4:11-9.
65. Chabannon C, Le Coroller AG, Faucher C, et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 1995;4:171-9.
66. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-9.
67. Dicke KA, Hood D, Hanks S. Peripheral blood stem cell collection after mobilization with intensive chemotherapy and growth factors. J Hematother 1994;3:141-4.
68. Emminger W, Emminger-Schmidmeier W, Hocker P, et al. The median daily increment of leukocytes during hematopoietic recovery reflects the myeloid progenitor cell yield during leukapheresis in children. Bone Marrow Transplant 1990;5:419-24.
69. Kotasek D, Shepherd KM, Sage RE, et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992;9:11-7.
70. Ghalie R, Richman CM, Bender JG, et al. Sequential transplants using mobilized peripheral blood progenitor cells. J Clin Apheresis 1994;9:176-82.
71. To LB, Stemmelin GR, Haylock DN, et al. Collection efficiency on the Fenwal CS3000 when using filgrastim (recombinant methionyl human granulocyte colony-stimulating factor) as a peripheral blood stem cell mobilization agent. J Clin Apheresis 1994;9:17-20.
72. Haylock DN, Canty A, Thorp D, et al. A discrepancy between the instantaneous and the overall collection efficiency of the Fenwal CS3000 for peripheral blood stem cell apheresis. J Clin Apheresis 1992;7:6-11.
73. Goldberg SL, Mangan KF, Klumpp TR, et al. Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses. J Hematother 1995;4:85-90.
74. Quillen K, Magarace L, Flanagan J, Berkman EM. Vascular erosion caused by a double-lumen central venous catheter during therapeutic plasma exchange. Transfusion 1995;35:510-2.
75. James P. Collection of peripheral blood stem cells on spectra. J Clin Apheresis 1994;9:33-4.
76. Rosenfeld CS, Cullis H, Tarosky T, Nemunaitis I. Peripheral blood stem cell collection using the small volume collection chamber in the Fenwal CS-3000 Plus blood cell separator. Bone Marrow Transplant 1994;13:131-4.
77. Takaue Y, Kawano Y, Abe T, et al. Collection and transplantation of peripheral blood stem cells in very small children weighing 20 kg or less. Blood 1995;86:372-80.
78. Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation (editorial). Bone Marrow Transplant 1994;13:353-5.
79. Kessinger A, Smith DM, Strandjord SE, et al. Allogeneic transplantation of blood-derived T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989;4:643-6.
80. Korbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-65.
81. Lane TA, Law P, Maruyama M, et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995;85:275-82.
82. Cobos E, Keung YK, Morgan D, Park CH. Successful engraftment using allogeneic peripheral blood progenitor cells in a patient with primary bone marrow graft failure. J Hematother 1995;4:37-40.
83. Weaver CH, Buckner CD, Login K, et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after administration of recombinant human granulocyte colony-stimulating factor. Blood 1993;82:1981-4.
84. Azevedo WM, Aranha FJ, Gouvea JV, et al. Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 1995;16:647-53.
85. Tanaka J, Kasai M, Imamura M, et al. Clinical application of allogeneic peripheral blood stem cells transplantation. Ann Hematol 1995;71:265-9.
86. Majolino I, Saglio G, Scimè R, et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996;17:555-60.
87. +-selected human peripheral blood progenitor cells. Blood 1994;84:2898-903.
88. Dreger P, Viehmann K, Steinmann J, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Exp Hematol 1995;23:147-54.
89. Arseniev L, Tischler HJ, Battmer K, et al. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994;14:791-7.
90. Berenson RJ, Bensinger WI, Kalamasz DF, et al. Transplantation of stem cells enriched by immunoadsorption. Prog Clin Biol Res 1992;377:449-57.
91. Gorin NC, Lopez M, Laporte JP, et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood 1995;85:1647-54.
92. Lebkowski JS, Schain LR, Okrongly D, et al. Rapid isolation of human CD34 hematopoietic stem cells - purging of human tumor cells. Transplantation 1992;53:1011-9.
93. Shpall EJ, Jones RB, Bearman SI, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
94. Sharp JG, Kessinger A, Vaughan WP, et al. Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Cloning 1992;10(Suppl):92-4.
95. Hawkins TE, Juttner CA. Blood cell transplantation. Curr Opin Oncol 1995;7:122-9.
96. Ross AA, Cooper BW, Lazarus HM, et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82:2605-10.
97. Hardingham JE, Kotasek D, Sage RE, et al. Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993;11:15-20.
98. Shpall EJ, Jones RB, Bearman SI, et al. Transplantation of CD34+ hematopoietic progenitor cells. J Hematother 1994;3:145-7.
99. Korbling M, Fleidner TM, Holle R, et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991;7:343-9.
100. Brugger W, Bross KJ, Glatt M, et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994;83:636-40.
101. Passos-Coelho JL, Ross AA, Moss TJ, et al. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1995;85:1138-43.
102. Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 1993;82:378-84.
103. Peters WP, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993;81:1709-19.
104. Chao NJ, Schriber JR, Grimes K, et al. Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993;81:2031-5.
105. Harousseau JL, Attal M, Divine M, et al. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. Bone Marrow Transplant 1995;15:963-9.
106. Liberti G, Pearce R, Taghipour G, et al. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT. Ann Oncol 1994;5 Suppl 2:151-3.
107. Beyer J, Schwella N, Zingsem J, et al. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995;13:1328-35.
108. Janssen WE, Smilee RC, Elfenbein GJ. A prospective randomized trial comparing blood- and marrow-derived stem cells for hematopoietic replacement following high-dose chemotherapy (letter). J Hematother 1995;4:139-40.
109. Juttner CA, To LB, Ho JQ, et al. Successful peripheral blood stem-cell autograft with a near-critical dose of myeloid progenitor cells in acute non-lymphoblastic leukaemia in relapse. Med J Aust 1987;147:292-3.
110. Kessinger A, Armitage JO, Landmark JD, et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-7.
111. To LB, Davy ML, Haylock DN, et al. Autotransplantation using peripheral blood stem cells mobilized by cyclophosphamide (letter). Bone Marrow Transplant 1989;4:595-6.
112. Korbling M, Holle R, Haas R, et al. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol 1990;8:978-85.
113. Scheid C, Pettengell R, Ghielmini M, et al. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1995;15:901-6.
114. Huan SD, Hester J, Spitzer G, et al. Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin. Blood 1992;79:3388-93.
115. Brugger W, Bross K, Frisch J, et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992;79:1193-200.
116. Elias AD, Ayash L, Anderson KC, et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992;79:3036-44.
117. Tepler I, Cannistra SA, Frei E 3rd, et al. Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. J Clin Oncol 1993;11:1583-91.
118. Brice P, Divine M, Marolleau JP, et al. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant 1994;14:51-5.
119. Eto T, Takamatsu Y, Harada M, et al. Effects of macrophage colony-stimulating factor (M-CSF) on the mobilization of peripheral blood stem cells. Bone Marrow Transplant 1994;13:125-9.
120. D'Hondt V, Guillaume T, Humblet Y, et al. Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multiagent chemotherapy: a pilot study. Bone Marrow Transplant 1994;13:261-4.
121. Zimmerman TM, Mick R, Myers S, et al. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy. Bone Marrow Transplant 1995;15:923-7.
122. Demirer T, Buckner CD, Appelbaum FR, et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995;15:915-22.
123. Kohno A, Takeyama K, Narabayashi M, et al. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor. Bone Marrow Transplant 1995;15:49-54.